Psychopharmacology with Special Populations Pre-Conference

Cultural Competency and Psychopharmacology*

Francis Lu, MD

​

Substance Use Disorders in Special Populations*

Carlos Tirado, MD

Treating Immigrant Populations*

Charles Dike, MD

Assessment and Psychotherapy
Recommendations with Culturally
Diverse Patients*

Martin La Roche, PhD

Treating Children of
Filipinx/a/o American Populations*

Bernice Ponce de Leon, DO

Treatment of Native American Populations*

Mary Roessel, MD

Considering Culture and Ethnicity in Prescribing*

Kenneth Fung, MD

Gender Issues in Prescribing Psychotropics*

Jami Woods, MD

* Qualifies for Cultural Competency CME (one hour each)

Psychopharmacology Update

Pharmacological Treatment of First Episode Psychosis

Jonathan Meyer, MD

Measurement Based Care in the 21st Century: Using Antipsychotic Levels

Jonathan Meyer, MD

New Medications for the Treatment of Schizophrenia

Stephen Marder, MD

Novel Treatments for Depression

Michael Thase, MD

Management of Treatment Resistant Depression

Gerald Maguire, MD

Treatment of Stuttering

Gerald Maguire, MD

Differentiating Medical from Psychiatric Symptoms

Theodore Stern, MD

Metabolomics and Mental Health

Kelly Olson, PhD

Networking opportunities with attendees and exhibitors! Spouses and guests welcome to attend.

Piano Concert and Lecture

Psychopharmacology Update

Recently Marketed Drugs for the Treatment of ADHD

Jeffrey Newcorn, MD

Disruptive Mood Dysregulation Disorder

Gabrielle Carlson, MD

Recognizing and Treating PANS/PANDAS

Kiki Chang, MD

Pediatric Post-COVID-19 Treatment

Laura Malone, MD, PhD

Genetics of Psychiatric Disorders

Thomas Schulze, MD

Managing Psychiatric Symptoms in Cancer Patients

Xiomara Rocha-Cadman, MD

Suicide Prevention and the 988 Hotline**

Deborah Pinals, MD

Treatment of Psychiatric Illness in the Homeless***

Hunter McQuiston, MD

**Qualifies for one hour of Suicide Prevention CME

***Qualifies for Ethics; Pain Management; or Addiction Care CME (one hour each)

Psychopharmacology Update

Treating Patients with Developmental Disabilities Across the Lifespan

Kyle Jones, MD

Integrative Psychiatry

Philip Muskin, MD, MA

Managing Drug-Drug Interactions (DDIs) in Psychiatric Practice

Sheldon Preskorn, MD

Use of Psychotropics in Pregnancy

Vivien Burt, MD

New Medications for Bipolar Disorder

Mark Frye, MD

Alcoholism Treatment and Targeted Comorbidities

Mark Frye, MD

Management of Opioid Use Disorders During a Pandemic***

Elinor McCance-Katz, MD, PhD

Controversial Issues in Treatment of Substance Use Disorders***

Elinor McCance-Katz, MD, PhD

***Qualifies for Ethics; Pain Management; or Addiction Care CME (one hour each)